US Patent 11179461 Ii vaccine adjuvant
Patent 11179461 was granted and assigned to University of Copenhagen on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+330 characters)
Article
Patent abstract
The present invention relates to a vaccine comprising a nucleic acid construct such as a DNA construct especially a nucleic acid construct comprising sequences encoding invariant chain operatively linked to antigenic protein or peptide encoding sequences. The present vaccine stimulates an enhanced immune response.
Edits on 10 Oct, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Cyrielle Elyette Fougeroux0
Peter Johannes Holst0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111794610
Date of Patent
November 23, 2021
0Patent Application Number
164843360
Date Filed
March 19, 2018
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 25 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11179461 Ii vaccine adjuvant
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11179461
Date of patent
November 23, 2021
Patent application number
16484336
Date Filed
March 19, 2018
Patent primary examiner
Find more entities like US Patent 11179461 Ii vaccine adjuvant
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
